- Motley Fool via Yahoo FinanceSep 05 1:39 AM
Business Standard describes pharma vehicles as laggards over the past year, with an average return of only 1.74% and returns of 4.9% compounded annually over the past five years. It would seem ...
Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical PayoffMSN News7 days ago
The biotech just announced a potentially game-changing acquisition.
- The Motley Fool1 day ago
- MSN News7 days ago
Vertex Pharmaceuticals' $950 Million Bet on Curing Type 1 Diabetes Could Have an Astronomical PayoffMotley Fool via Yahoo FinanceSep 04 12:00 PM
Vertex is also developing drugs for treating pain in addition to other rare genetic diseases, including alpha-1 antitrypsin deficiency (AATD), beta-thalassemia, Duchenne muscular dystrophy ...
- related to AATD